These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15790328)

  • 1. Cyclic bisphosphonate therapy in osteogenesis imperfecta type V.
    Fleming F; Woodhead HJ; Briody JN; Hall J; Cowell CT; Ault J; Kozlowski K; Sillence DO
    J Paediatr Child Health; 2005 Mar; 41(3):147-51. PubMed ID: 15790328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta.
    Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E
    Turk J Pediatr; 2004; 46(4):322-8. PubMed ID: 15641265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.
    Munns CF; Rauch F; Zeitlin L; Fassier F; Glorieux FH
    J Bone Miner Res; 2004 Nov; 19(11):1779-86. PubMed ID: 15476577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.
    Dimeglio LA; Ford L; McClintock C; Peacock M
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):43-53. PubMed ID: 15679068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate therapy for severe osteogenesis imperfecta.
    Glorieux FH
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():989-92. PubMed ID: 11086652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.
    Glorieux FH; Bishop NJ; Plotkin H; Chabot G; Lanoue G; Travers R
    N Engl J Med; 1998 Oct; 339(14):947-52. PubMed ID: 9753709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
    Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
    J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous pamidronate treatment in children with osteogenesis imperfecta.
    Atta I; Iqbal F; Lone SW; Ibrahim M; Khan YN; Raza J
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):653-7. PubMed ID: 25233970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteogenesis imperfecta: a new, early therapeutic approach with biphosphonates. A case report].
    Guillot M; Eckart P; Desrosieres H; Amiour M; al-Jazayri Z
    Arch Pediatr; 2001 Feb; 8(2):172-5. PubMed ID: 11232458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.
    Shapiro JR; Thompson CB; Wu Y; Nunes M; Gillen C
    Calcif Tissue Int; 2010 Aug; 87(2):120-9. PubMed ID: 20544187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant.
    Chien YH; Chu SY; Hsu CC; Hwu WL
    J Inherit Metab Dis; 2002 Nov; 25(7):593-5. PubMed ID: 12638943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].
    Chigladze TT; Zhvaniia MA; Bekua MV
    Georgian Med News; 2006 Feb; (131):62-5. PubMed ID: 16575136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta.
    Devogelaer JP; Malghem J; Maldague B; Nagant de Deuxchaisnes C
    Skeletal Radiol; 1987; 16(5):360-3. PubMed ID: 3629280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.
    Aström E; Jorulf H; Söderhäll S
    Arch Dis Child; 2007 Apr; 92(4):332-8. PubMed ID: 17114205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.
    Land C; Rauch F; Munns CF; Sahebjam S; Glorieux FH
    Bone; 2006 Oct; 39(4):901-6. PubMed ID: 16730480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful results of pamidronate treatment in children with osteogenesis imperfecta with emphasis on the interpretation of bone mineral density for local standards.
    Poyrazoglu S; Gunoz H; Darendeliler F; Bas F; Tutunculer F; Eryilmaz SK; Bundak R; Saka N
    J Pediatr Orthop; 2008 Jun; 28(4):483-7. PubMed ID: 18520289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta.
    Biggin A; Zheng L; Briody JN; Coorey CP; Munns CF
    Horm Res Paediatr; 2015; 83(3):183-9. PubMed ID: 25676713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.